Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-11T12:19:04.217Z Has data issue: false hasContentIssue false
  • English
  • Français

ProsorbaR Treatment Column: A Device that Removes Circulating Immune Complexes (CIC), IgG, and Autoimmune Antibodies From Patient Plasma

Published online by Cambridge University Press:  26 February 2011

Joseph P. Balint Jr ,
Frank R. Jones ,
Harry W. Snyder Jr.  and
ProsorbaR Column Clinical Trial Group.
Joseph P. Balint Jr
Affiliation:
IMRE Corporation, 130 Fifth Avenue North, Seattle, WA 98109
Frank R. Jones
Affiliation:
IMRE Corporation, 130 Fifth Avenue North, Seattle, WA 98109
Harry W. Snyder Jr.
Affiliation:
IMRE Corporation, 130 Fifth Avenue North, Seattle, WA 98109
Get access

Abstract

Selective removal of molecular moieties from plasma of patients can result in tumor regression, auto-antibody clearance, and immune modulation. The ProsorbaR Column consists of highly purified protein A isolated from Staphylococcus and covalently linked to inert silica housed in a polycarbonate device. Protein A acts as an immunoadsorbent to selectively remove immunoglobulin G (IgG) and IgG containing CIC via specific binding to the Fc fragment of IgG. Columns were sterile, disposable devices that remove approximately one gram of IgG from plasma per treatment. As part of a multicenter clinical trial, 8 of 22 (36%) end stage breast cancer patients exhibited objective antitumor responses. Treatment of 24 patients with immune thrombocytopenia resulted in 14 (58%) of patients having objective increases in platelet counts and clearance or significant reduction of anti-platelet antibody. The mechanism of action of this device is unknown at present but may be selective removal of IgG and CIC, and activation of factors such as the complement system which results in enhanced reticuloendothelial system (RES) clearance of CIC. In addition, immune modulation may result due to the stimulation of anti-idiotypic antibodies and selective clonal deletion of auto-antibody producing lymphocyte sub-populations.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 110: Symposium M – Biomedical Materials and Devices , 1987 , 761
Copyright
Copyright © Materials Research Society 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Weetall, H.H. and Filbert, A.M., in Methods in Enzymology, Edited by Jacoby, W.B. and Wilchek, M. (Academic Press, New York, 1974), p. 59 Google Scholar
2. Laemmli, U.K., Nature 227, 680, (1970)Google Scholar
3. Lindmark, R., Thoren-Tolling, K., and Sjoquist, J., J. Immunol. Methods 62, 1, (1983)Google Scholar
4. Langone, J.J., Adv. Immunol. 32, 157, (1982)Google Scholar
5. Kessler, S.W., J. Immunol. 115, 1617, (1975)Google Scholar
6. McDougal, J.S., Redecha, P.B., Inman, R.D., and Christian, C.L., J. Clin. Invest. 63, 627, (1979)Google Scholar
7. Langone, J.J., Biochem, Biophys. Res. Comm. 94, 473, (1980)Google Scholar
8. Snyder, H.W. Jr., Ernst, N.R., Grosmaire, L.S., Balint, J.P., Yoshida, L.H., and Jones, F.R., J. Immunol. Methods 101, 209, (1987)Google Scholar
9. Messerschmidt, G.L. et. al., J. Clin. Oncology In Press (1988)Google Scholar
10. Aster, R.H., in Hematology, Edited by Williams, W.J., Beutler, E., Erslev, A.J., and Lichtman, M.A. (McGraw-Hill, New York, 1983), p. 1320 Google Scholar
11. Theofilopoulos, A.N. and Dixon, F.J., Amer. J. Pathol. 100, 531, (1980)Google Scholar